Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Verrica Pharmaceuticals Inc (VRCA) Tops Q4 EPS by 5c streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Dermatological Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com s offering. World revenue for Dermatological Drugs.
WEST CHESTER, Pa., Feb. 27, 2024 Verrica Pharmaceuticals Inc. , a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that.
/PRNewswire/ Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that.